A citation-based method for searching scientific literature

Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist, Bingjian Feng, Rachel McFarland, Tina Pesaran, Robert Huether, Holly LaDuca, Elizabeth C Chao, David E Goldgar, Jill S Dolinsky. JAMA Oncol 2017
Times Cited: 269



Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold, Seth Slettedahl, Emily Hallberg, Lucia Guidugli, Jaime I Davila, Matthias W Beckmann, Wolfgang Janni, Brigitte Rack, Arif B Ekici, Dennis J Slamon, Irene Konstantopoulou, Florentia Fostira, Athanassios Vratimos, George Fountzilas, Liisa M Pelttari, William J Tapper, Lorraine Durcan, Simon S Cross, Robert Pilarski, Charles L Shapiro, Jennifer Klemp, Song Yao, Judy Garber, Angela Cox, Hiltrud Brauch, Christine Ambrosone, Heli Nevanlinna, Drakoulis Yannoukakos, Susan L Slager, Celine M Vachon, Diana M Eccles, Peter A Fasching. J Clin Oncol 2015
Times Cited: 355




List of shared articles



Times cited

Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients.
Renan Gomes, Pricila da Silva Spinola, Ayslan Castro Brant, Bruna Palma Matta, Caroline Macedo Nascimento, Silvia Maria de Aquino Paes, Cibele Rodrigues Bonvicino, Anna Claudia Evangelista Dos Santos, Miguel Angelo Martins Moreira. Breast Cancer Res Treat 2021
1

The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.
Ciyu Yang, Angela G Arnold, Amanda Catchings, Vikas Rai, Zsofia K Stadler, Liying Zhang. Breast Cancer Res Treat 2021
0

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Chunling Hu, Steven N Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas J Boddicker,[...]. N Engl J Med 2021
39

BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.
Paula Rofes, Jesús Del Valle, Sara Torres-Esquius, Lídia Feliubadaló, Agostina Stradella, José Marcos Moreno-Cabrera, Adriana López-Doriga, Elisabet Munté, Rafael De Cid, Olga Campos,[...]. Genes (Basel) 2021
0


Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Marius Wunderle, Lothar Häberle, Alexander Hein, Sebastian M Jud, Michael P Lux, Carolin C Hack, Julius Emons, Felix Heindl, Naiba Nabieva, Christian R Loehberg,[...]. Breast Care (Basel) 2021
0

Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Yifan Wu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie. Breast Cancer Res Treat 2020
2

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort.
Chunling Hu, Eric C Polley, Siddhartha Yadav, Jenna Lilyquist, Hermela Shimelis, Jie Na, Steven N Hart, David E Goldgar, Swati Shah, Tina Pesaran,[...]. J Natl Cancer Inst 2020
14

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Julie R Palmer, Eric C Polley, Chunling Hu, Esther M John, Christopher Haiman, Steven N Hart, Mia Gaudet, Tuya Pal, Hoda Anton-Culver, Amy Trentham-Dietz,[...]. J Natl Cancer Inst 2020
17